These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 34502257)

  • 21. Protease-activated receptor signalling by coagulation proteases in endothelial cells.
    Rezaie AR
    Thromb Haemost; 2014 Nov; 112(5):876-82. PubMed ID: 24990498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathophysiological actions of protease activated receptors (PARs).
    Pandya NM; Jain SM; Santani DD
    Pharmazie; 2007 Mar; 62(3):163-9. PubMed ID: 17416190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protease-activated receptors in inflammation, neuronal signaling and pain.
    Vergnolle N; Wallace JL; Bunnett NW; Hollenberg MD
    Trends Pharmacol Sci; 2001 Mar; 22(3):146-52. PubMed ID: 11239578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trypsin IV or mesotrypsin and p23 cleave protease-activated receptors 1 and 2 to induce inflammation and hyperalgesia.
    Knecht W; Cottrell GS; Amadesi S; Mohlin J; Skåregärde A; Gedda K; Peterson A; Chapman K; Hollenberg MD; Vergnolle N; Bunnett NW
    J Biol Chem; 2007 Sep; 282(36):26089-100. PubMed ID: 17623652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reaction of mast cell proteases tryptase and chymase with protease activated receptors (PARs) on keratinocytes and fibroblasts.
    Schechter NM; Brass LF; Lavker RM; Jensen PJ
    J Cell Physiol; 1998 Aug; 176(2):365-73. PubMed ID: 9648924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proteinase-activated receptors.
    Macfarlane SR; Seatter MJ; Kanke T; Hunter GD; Plevin R
    Pharmacol Rev; 2001 Jun; 53(2):245-82. PubMed ID: 11356985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protease-activated receptors in the brain: receptor expression, activation, and functions in neurodegeneration and neuroprotection.
    Luo W; Wang Y; Reiser G
    Brain Res Rev; 2007 Dec; 56(2):331-45. PubMed ID: 17915333
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protease-activated receptors: protease signaling in the gastrointestinal tract.
    Amadesi S; Bunnett N
    Curr Opin Pharmacol; 2004 Dec; 4(6):551-6. PubMed ID: 15525542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Review article: proteinase-activated receptors - novel signals for gastrointestinal pathophysiology.
    Vergnolle N
    Aliment Pharmacol Ther; 2000 Mar; 14(3):257-66. PubMed ID: 10735917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Four subtypes of protease-activated receptors, co-expressed in rat astrocytes, evoke different physiological signaling.
    Wang H; Ubl JJ; Reiser G
    Glia; 2002 Jan; 37(1):53-63. PubMed ID: 11746783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biased signalling and proteinase-activated receptors (PARs): targeting inflammatory disease.
    Hollenberg MD; Mihara K; Polley D; Suen JY; Han A; Fairlie DP; Ramachandran R
    Br J Pharmacol; 2014 Mar; 171(5):1180-94. PubMed ID: 24354792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thrombin receptor: An endogenous inhibitor of inflammatory pain, activating opioid pathways.
    Martin L; Augé C; Boué J; Buresi MC; Chapman K; Asfaha S; Andrade-Gordon P; Steinhoff M; Cenac N; Dietrich G; Vergnolle N
    Pain; 2009 Nov; 146(1-2):121-9. PubMed ID: 19674841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of protease-activated receptor-2 in inflammation, and its possible implications as a putative mediator of periodontitis.
    Holzhausen M; Spolidorio LC; Vergnolle N
    Mem Inst Oswaldo Cruz; 2005 Mar; 100 Suppl 1():177-80. PubMed ID: 15962119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enzyme specificity and effects of gyroxin, a serine protease from the venom of the South American rattlesnake Crotalus durissus terrificus, on protease-activated receptors.
    Yonamine CM; Kondo MY; Nering MB; Gouvêa IE; Okamoto D; Andrade D; da Silva JA; Prieto da Silva AR; Yamane T; Juliano MA; Juliano L; Lapa AJ; Hayashi MA; Lima-Landman MT
    Toxicon; 2014 Mar; 79():64-71. PubMed ID: 24412460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure, function and pathophysiology of protease activated receptors.
    Adams MN; Ramachandran R; Yau MK; Suen JY; Fairlie DP; Hollenberg MD; Hooper JD
    Pharmacol Ther; 2011 Jun; 130(3):248-82. PubMed ID: 21277892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The cardiovascular actions of protease-activated receptors.
    Steinberg SF
    Mol Pharmacol; 2005 Jan; 67(1):2-11. PubMed ID: 15371558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proteolysis of the exodomain of recombinant protease-activated receptors: prediction of receptor activation or inactivation by MALDI mass spectrometry.
    Loew D; Perrault C; Morales M; Moog S; Ravanat C; Schuhler S; Arcone R; Pietropaolo C; Cazenave JP; van Dorsselaer A; Lanza F
    Biochemistry; 2000 Sep; 39(35):10812-22. PubMed ID: 10978167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neutrophil serine proteinases activate human nonepithelial cells to produce inflammatory cytokines through protease-activated receptor 2.
    Uehara A; Muramoto K; Takada H; Sugawara S
    J Immunol; 2003 Jun; 170(11):5690-6. PubMed ID: 12759451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Co-existence of two types of [Ca2+]i-inducing protease-activated receptors (PAR-1 and PAR-2) in rat astrocytes and C6 glioma cells.
    Ubl JJ; Vöhringer C; Reiser G
    Neuroscience; 1998 Sep; 86(2):597-609. PubMed ID: 9881872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more.
    Ramachandran R; Hollenberg MD
    Br J Pharmacol; 2008 Mar; 153 Suppl 1(Suppl 1):S263-82. PubMed ID: 18059329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.